Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysis

Background Some adipose-related parameters exhibit distinct prognostic value in patients with cirrhosis. However, the magnitude and direction of the association between individual adipose parameter and mortality in patients with cirrhosis are unclear.Aim This study aimed to evaluate the association...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang Wen, Shuyue Tuo, Qiuju Ran, Jia Yuan, Yong Li, Ying Zhang, Danyan Chang, Chan Li, Shejiao Dai, Jinhai Wang, Xinxing Tantai
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2025.2473627
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850108321072152576
author Zhang Wen
Shuyue Tuo
Qiuju Ran
Jia Yuan
Yong Li
Ying Zhang
Danyan Chang
Chan Li
Shejiao Dai
Jinhai Wang
Xinxing Tantai
author_facet Zhang Wen
Shuyue Tuo
Qiuju Ran
Jia Yuan
Yong Li
Ying Zhang
Danyan Chang
Chan Li
Shejiao Dai
Jinhai Wang
Xinxing Tantai
author_sort Zhang Wen
collection DOAJ
description Background Some adipose-related parameters exhibit distinct prognostic value in patients with cirrhosis. However, the magnitude and direction of the association between individual adipose parameter and mortality in patients with cirrhosis are unclear.Aim This study aimed to evaluate the association between individual adipose parameter and mortality in patients with cirrhosis using the meta-analysis method.Methods The PubMed, Embase, Web of Science, China Biological Medicine, WanFang, and China National Knowledge Infrastructure databases were searched from inception through December 15, 2023, to identify eligible studies. The impact of each adipose parameter on mortality was assessed by the pooled unadjusted or adjusted hazard ratio (HR) with 95% confidence intervals (CIs) using the random effects model.Results A total of 33 studies involving 9626 patients were included in our analysis, with 11 adipose parameters evaluated. The pooled prevalence of sarcopenic obesity (SO) and myosteatosis in patients with cirrhosis was 15.5% and 34.4%, respectively. In adjusted analysis, each unit increase in subcutaneous adipose tissue index (SATI) (HR: 0.99, 95% CI: 0.98–1.00) or muscle attenuation (MA) (HR: 0.94, 95% CI: 0.90–0.98) and each unit decrease in visceral-to-subcutaneous adipose tissue ratio (VSR) (HR: 1.92, 95% CI: 1.45–2.54) showed an independent association with a decreased risk of mortality. However, concurrent myosteatosis (HR: 1.88, 95% CI: 1.48–2.40) or SO (HR: 2.77, 95% CI: 1.95–3.93) significantly increased the risk of mortality in patients with cirrhosis.Conclusion Decreased SATI or MA, increased VSR, and concurrent myosteatosis or SO were independently associated with a higher risk of mortality in patients with cirrhosis.
format Article
id doaj-art-9b5abe71cf1b4fd98e8eb806fa210032
institution OA Journals
issn 0785-3890
1365-2060
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj-art-9b5abe71cf1b4fd98e8eb806fa2100322025-08-20T02:38:23ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602025-12-0157110.1080/07853890.2025.2473627Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysisZhang Wen0Shuyue Tuo1Qiuju Ran2Jia Yuan3Yong Li4Ying Zhang5Danyan Chang6Chan Li7Shejiao Dai8Jinhai Wang9Xinxing Tantai10Department of Gastroenterology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaDepartment of Gastroenterology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaDepartment of Gastroenterology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaDepartment of Gastroenterology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaDepartment of Gastroenterology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaDepartment of Gastroenterology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaDepartment of Gastroenterology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaDepartment of Gastroenterology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaDepartment of Gastroenterology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaDepartment of Gastroenterology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaDepartment of Gastroenterology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, ChinaBackground Some adipose-related parameters exhibit distinct prognostic value in patients with cirrhosis. However, the magnitude and direction of the association between individual adipose parameter and mortality in patients with cirrhosis are unclear.Aim This study aimed to evaluate the association between individual adipose parameter and mortality in patients with cirrhosis using the meta-analysis method.Methods The PubMed, Embase, Web of Science, China Biological Medicine, WanFang, and China National Knowledge Infrastructure databases were searched from inception through December 15, 2023, to identify eligible studies. The impact of each adipose parameter on mortality was assessed by the pooled unadjusted or adjusted hazard ratio (HR) with 95% confidence intervals (CIs) using the random effects model.Results A total of 33 studies involving 9626 patients were included in our analysis, with 11 adipose parameters evaluated. The pooled prevalence of sarcopenic obesity (SO) and myosteatosis in patients with cirrhosis was 15.5% and 34.4%, respectively. In adjusted analysis, each unit increase in subcutaneous adipose tissue index (SATI) (HR: 0.99, 95% CI: 0.98–1.00) or muscle attenuation (MA) (HR: 0.94, 95% CI: 0.90–0.98) and each unit decrease in visceral-to-subcutaneous adipose tissue ratio (VSR) (HR: 1.92, 95% CI: 1.45–2.54) showed an independent association with a decreased risk of mortality. However, concurrent myosteatosis (HR: 1.88, 95% CI: 1.48–2.40) or SO (HR: 2.77, 95% CI: 1.95–3.93) significantly increased the risk of mortality in patients with cirrhosis.Conclusion Decreased SATI or MA, increased VSR, and concurrent myosteatosis or SO were independently associated with a higher risk of mortality in patients with cirrhosis.https://www.tandfonline.com/doi/10.1080/07853890.2025.2473627Liver cirrhosisadipose tissuebody compositionsurvivalmeta-analysis
spellingShingle Zhang Wen
Shuyue Tuo
Qiuju Ran
Jia Yuan
Yong Li
Ying Zhang
Danyan Chang
Chan Li
Shejiao Dai
Jinhai Wang
Xinxing Tantai
Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysis
Annals of Medicine
Liver cirrhosis
adipose tissue
body composition
survival
meta-analysis
title Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysis
title_full Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysis
title_fullStr Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysis
title_full_unstemmed Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysis
title_short Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysis
title_sort effect of adipose related parameters on mortality in patients with liver cirrhosis a meta analysis
topic Liver cirrhosis
adipose tissue
body composition
survival
meta-analysis
url https://www.tandfonline.com/doi/10.1080/07853890.2025.2473627
work_keys_str_mv AT zhangwen effectofadiposerelatedparametersonmortalityinpatientswithlivercirrhosisametaanalysis
AT shuyuetuo effectofadiposerelatedparametersonmortalityinpatientswithlivercirrhosisametaanalysis
AT qiujuran effectofadiposerelatedparametersonmortalityinpatientswithlivercirrhosisametaanalysis
AT jiayuan effectofadiposerelatedparametersonmortalityinpatientswithlivercirrhosisametaanalysis
AT yongli effectofadiposerelatedparametersonmortalityinpatientswithlivercirrhosisametaanalysis
AT yingzhang effectofadiposerelatedparametersonmortalityinpatientswithlivercirrhosisametaanalysis
AT danyanchang effectofadiposerelatedparametersonmortalityinpatientswithlivercirrhosisametaanalysis
AT chanli effectofadiposerelatedparametersonmortalityinpatientswithlivercirrhosisametaanalysis
AT shejiaodai effectofadiposerelatedparametersonmortalityinpatientswithlivercirrhosisametaanalysis
AT jinhaiwang effectofadiposerelatedparametersonmortalityinpatientswithlivercirrhosisametaanalysis
AT xinxingtantai effectofadiposerelatedparametersonmortalityinpatientswithlivercirrhosisametaanalysis